Our Research

TCRW research is shaped by expertise from our five partnering hospitals across Dublin, and our patient representatives and advocacy groups. 

A commitment to inclusion, equity and access underpins all our research themes, guiding how we design studies and translate evidence into practice and policy.

Our research themes are interconnected and strengthened by collaboration, innovation and a shared commitment improving outcomes for women and people affected by reproductive disorders. 

Publication and Dissemination

A-Z

Baldwin, M. K., et al. (2023). Building the foundation for a community‑generated national research blueprint for inherited bleeding disorders. https://doi.org/10.1080/17474086.2023.2175660 

Browning, J., et al. (2024). Membrane‑bound receptor for advanced glycation end products (RAGE) as a biomarker of low‑quality sperm. https://doi.org/10.1093/hropen/hoae064 

Crosby, D. A., et al. (2020). Dysregulation of the interleukin‑17A pathway in endometrial tissue from women with unexplained infertility. https://doi.org/10.1093/humrep/deaa111 

Fee, N., et al. (2026). Outcomes of adolescents and young adults attending fertility counselling and oocyte cryopreservation prior to gonadotoxic treatment. https://doi.org/10.1007/s10815-026-03889-z 

Glover, L. E., et al. (2018). Uterine natural killer cell progenitor populations predict successful implantation in endometriosis‑associated infertility. https://doi.org/10.1111/aji.12817

Giangrazi, F., et al. (2026). Contribution of endometrial microbiome to inflammation‑mediated infertility in women undergoing ART. https://doi.org/10.1093/humrep/deaf252 

Lavin, M., et al. (2018). Significant gynecological bleeding in women with low von Willebrand factor levels. https://doi.org/10.1182/bloodadvances.2018017418 

O’Donnell, M., et al. (2026). Menstrual outcomes are frequently overlooked in von Willebrand disease trials. https://doi.org/10.1016/j.rpth.2026.106623 

Scheres, L. J. J., et al. (2026). Reducing mortality, improving outcomes, and establishing equity for women with classical haematological disease. https://doi.org/10.1016/S2352-3026(26)00079-7 

van Galen, K., et al. (2021). European principles of care for women and girls with inherited bleeding disorders. https://doi.org/10.1111/hae.14379 

A-Z

Bourke, N. M., et al. (2022). Human IFNε: Spatiotemporal expression, hormone regulation and innate immunity in the female reproductive tract. https://doi.org/10.1172/jci.insight.135407 

Dyer, A. H., et al. (2026). Systemic inflammation, delirium and clinical progression in mild‑moderate Alzheimer disease. https://doi.org/10.1016/j.ebiom.2026.106159 

Fung, K. Y., et al. (2024). Expression of interferon epsilon in mucosal epithelium is regulated by Elf3. https://doi.org/10.1128/mcb.334-343 

Marks, Z. R. C., et al. (2023). Interferon‑ε is a tumour suppressor and restricts ovarian cancer. https://doi.org/10.1038/s41586-023-06441-4 

Smith, N., et al. (2022). Defective activation and regulation of type I interferon immunity associated with increasing COVID‑19 severity. https://doi.org/10.1038/s41467-022-34945-7 

Ward, M. P., et al. (2021). Procoagulant activity in high‑grade serous ovarian cancer following neoadjuvant chemotherapy. https://doi.org/10.1016/j.thromres.2021.01.012 

Kelly, T. E., et al. (2023). Plasminogen activator inhibitor‑1 in high‑grade serous ovarian cancer metastasis and chemotherapy response. https://doi.org/10.3389/fcell.2023.1150991 

Norris, L. A., et al. (2020). Thrombogyn score for prediction of venous thromboembolism in gynecologic cancer. https://doi.org/10.1002/rth2.12342 

Ibrahim, E., et al. (2021). Extended prophylaxis for venous thromboembolism following surgery for gynaecological cancers. https://doi.org/10.1016/j.tru.2021.100038 

A-Z

Antosik‑Parsons, K., et al. (2025). Gender, nation and reproduction after repeal and decriminalisation. https://doi.org/10.1177/07916035251342136 

Antosik‑Parsons, K., Conlon, C., & Duffy, D. N. (2025). After the review: What next for Irish abortion services? https://doi.org/10.1177/07916035251360088 

Bratt, K., et al. (2026). Early medical abortion in Irish general practice: ADAPT data and telemedicine as routine care. https://doi.org/10.1136/bmjsrh-2026-203296 

Conlon, C. (2024). Variants of abortion exceptionalism: mapping adherence to healthcare standards. (Book chapter). 

Conlon, C., Antosik‑Parsons, K., & Butler, É. (2025). Experiences of the Irish model of community medical abortion. https://doi.org/10.1080/07907184.2024.2369335 

Conlon, C., et al. (2022). Unplanned Pregnancy and Abortion Care (UnPAC) Study. http://www.tara.tcd.ie/handle/2262/101813 

Favier, M., & Conlon, C. (2025). Abortion provision in Ireland: implementation and advocacy. https://doi.org/10.1177/07916035251345356 

Honey, A., et al. (2025). Supporting parents with disability through occupational therapy. https://doi.org/10.1111/1440-1630.70026 

Codd, Y., et al. (2023). Impact of early inflammatory arthritis on parenting roles. https://doi.org/10.1080/09638288.2021.2006745 

White, C., et al. (2026). Lived experience of parenting with inflammatory arthritis. (Qualitative evidence synthesis)

Mazhak, I., et al. (2023–2025). Health, stress, anxiety and inequalities among Ukrainian female refugees.

Kennedy, M., et al. (2024–2026). Physical activity, heavy menstrual bleeding, and physiotherapy care for women with inherited bleeding disorders.

Ireland’s Maternity Safety Statements (2026). National model for transparent reporting. 

Maternal Safety Comparative Report (2024). Comparative maternal outcomes across Irish units.

Patient Advocacy and Engagement

Patient Advocacy and Engagement will appear here

Patient Advocacy and Engagement will appear here

Patient Advocacy and Engagement will appear here

Clinical Trials Directory

Ongoing and Completed Clinical Trials will appear here 

Ongoing and Completed Clinical Trials will appear here

Ongoing and Completed Clinical Trials will appear here